Hidradenitis suppurativa (HS) is often diagnosed late, complicating management. In this nationwide Danish study including 10,196 patients with dermatologist‐verified HS, we examined treatment patterns before and after referral to specialised hospital care.
Nana A. L. Rosenø +8 more
wiley +1 more source
Progressive Metastatic Cutaneous <i>TFCP2::FUS</i> Fusion-Positive Rhabdomyosarcoma: A Case Report. [PDF]
Reich D +4 more
europepmc +1 more source
Staging of the Axilla in Breast Cancer and the Evolving Role of Axillary Ultrasound
Michael Y. Chen, William E. Gillanders
openalex +2 more sources
Experimental Assessment of Wireless Monitoring of Axilla Temperature by Means of Epidermal Battery-Less RFID Sensors [PDF]
Francesca Camera +4 more
openalex +1 more source
Translational and real-world evidence of trastuzumab biosimilar CT-P6 plus pertuzumab in neoadjuvant HER2-positive early breast cancer. [PDF]
Alonso-Romero JL +12 more
europepmc +1 more source
Lymphangioma of the Axilla [PDF]
openaire +2 more sources
Is There a Tradeoff in Using Modified High Tangent Field Radiation for Treating an Undissected Node Positive Axilla? [PDF]
Himanshu Nagar +8 more
openalex +1 more source
ABSTRACT Background Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterised by painful nodules, abscesses, and draining and non‐draining tunnels. Currently, there are two biologics approved in Canada for the treatment of moderate‐to‐severe HS, adalimumab (anti‐TNF) and secukinumab (anti‐IL‐17A).
Irina Turchin +4 more
wiley +1 more source
Eosinophilic Granulomatosis With Polyangiitis Presenting as Mononeuritis Multiplex in a Diabetic Patient: Diagnostic and Therapeutic Challenges. [PDF]
Ahmed W +4 more
europepmc +1 more source
Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy [PDF]
Jacqueline S. Jeruss +9 more
openalex +1 more source

